Zura Bio Ltd (ZURA) — 10-Q Filings

10-Q Filings (7)

• 10-Q Filing — May 7, 2026
• Zura Bio's Q3 Loss Narrows, R&D Soars on Phase 2 Progress — Nov 13, 2025 Risk: high
  Zura Bio Ltd (ZURA) reported a net loss of $18.04 million for the three months ended September 30, 2025, a decrease from the $20.70 million net loss in the same
• Zura Bio's Losses Widen Amid Increased R&D for Lead Drug — Aug 14, 2025 Risk: high
  Zura Bio Ltd. (ZURA) reported a net loss of $15.993 million for the three months ended June 30, 2025, an increase from $10.329 million in the same period of 202
• Zura Bio Ltd. Files Q1 2025 10-Q — May 8, 2025 Risk: medium
  Zura Bio Ltd. filed its 10-Q for the period ending March 31, 2025. The company, formerly JATT Acquisition Corp, is in the biological products sector. Key dates
• Zura Bio Ltd. 10-Q: Cash Down, Capital Raised — Nov 7, 2024 Risk: medium
  Zura Bio Ltd. filed its 10-Q for the period ending September 30, 2024. The company reported cash and cash equivalents of $43.6 million as of September 30, 2024,
• Zura Bio Ltd. Reports Q2 2024 Net Loss of $63.7M — Aug 13, 2024 Risk: medium
  Zura Bio Ltd. reported a net loss of $63.7 million for the six months ended June 30, 2024, compared to a net loss of $43.6 million for the same period in 2023.
• Zura Bio Ltd Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
  Zura Bio Ltd (ZURA) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Zura Bio Ltd filed a 10-Q report for the period ending March 31, 2024. The comp

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX